Fluoro2 Therapeutics
PrivateCompany Overview
Fluoro2 Therapeutics is a biotechnology company developing a perfluorocarbon nanoemulsion designed as an artificial blood substitute for use in trauma, hemorrhage, and other medical situations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
blood substituteartificial bloodperfluorocarbonoxygen carriernanoemulsionbiotechnologymedical devicetrauma caretransfusion medicineGMP manufacturingsynthetic therapeuticsblood shortage solution
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fluoro2 Therapeutics Comparables
Compare Fluoro2 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| KaloCyte, Inc. | 84% | |
| VirTech Bio | 84% | |
| HbO2 Therapeutics | 84% | |
Fluoro2 Therapeutics Funding Rounds
Historical fundraising activity
Fluoro2 Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Fluoro2 Therapeutics's valuation, stock price, and market status.
See something wrong or outdated?